Nature: At last, a pill that can prevent #COVID1 after exposure to infected people
The prescription drug, called ensitrelvir, is currently approved in Japan and Singapore for treating mild-to-moderate COVID-19, it is under review by the U.S. FDA with a decision date set for June 16, 2026, as a potential post-exposure prophylaxis (PEP) to prevent infection.





